Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if one drug is superior to another with regard to safety and the preservation of renal function after a kidney transplant.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT07415421 · Hyperparathyroidism, Kidney Transplantation Recipients
NCT04748770 · Kidney Transplant Access, Obese Patients, and more
NCT05711446 · Urinary Tract Infections, Kidney Transplant; Complications
NCT05753930 · Kidney Transplantation in Highly Sensitized Patients
NCT07531966 · Kidney Transplant Recipient, Kidney Transplant; Complications, and more
San Diego, California
San Francisco, California
Denver, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions